Page 226 - IJB-9-2

International Journal of Bioprinting Three-dimensional bioprinting in toxicological research

Liver support therapy: an overview of the AMC-bioartificial Pharmaceutics, 12: 413.
liver research. Dig Surg, 22: 254–264.
https://doi.org/10.3390/pharmaceutics12050413
https://doi.org/10.1159/000088055
144. Turetta M, Ben FD, Brisotto G, et al., 2018, Emerging
141. Kammerer S, 2021, Three-dimensional liver culture systems technologies for cancer research: Towards personalized
to maintain primary hepatic properties for toxicological medicine with microfluidic platforms and 3D tumor models.
analysis in vitro. Int J Mol Sci, 22: 1024. Curr Med Chem, 25: 4616–4637.
https://doi.org/10.3390/ijms221910214 https://doi.org/10.2174/0929867325666180605122633
142. Algahtani MS, 2021, Assessment of pharmacist’s knowledge 145. Liu Y, Chen YG, 2018, 2D-and 3D-based intestinal stem cell
and perception toward 3D printing technology as a cultures for personalized medicine. Cells, 7: 225.
dispensing method for personalized medicine and the
readiness for implementation. Pharmacy (Basel), 9: 68. https://doi.org/10.3390/cells7120225
https://doi.org/10.3390/pharmacy9010068 146. Elcin YM, 2017, Special issue: Organs-on-chips &
3D-Bioprinting technologies for personalized medicine.
143. Joseph JF, Gronbach L, Garcia-Miller J, et al., 2020,
Automated real-time tumor pharmacokinetic profiling in Stem Cell Rev Rep, 13: 319–320.
3D models: A novel approach for personalized medicine. https://doi.org/10.1007/s12015-017-9744-2

Volume 9 Issue 2 (2023) 218 https://doi.org/10.18063/ijb.v9i2.663